Revvity To Acquire Human Cell Design To Advance Human-Relevant Cell Models For Metabolic Disease Drug Discovery - RVTY News | RalliesRevvity To Acquire Human Cell Design To Advance Human-Relevant Cell Models For Metabolic Disease Drug Discovery
R
RVTY• Revvity to acquire Human Cell Design
- Revvity, Inc. said it will acquire Human Cell Design to advance human-relevant cell models for metabolic disease drug discovery.
- Additional terms of the transaction were not disclosed.
- Revvity said the acquisition adds HCD's human pancreatic beta cell models to its portfolio.
ABM
•
